Literature DB >> 15270901

Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.

K Mizutani, Y Tamada, K Hara, T Tsuzuki, H Saeki, K Tamaki, Y Matsumoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15270901     DOI： 10.1111/j.1365-2133.2004.06024.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  14 in total

Review 1.  Targeted therapy for dermatofibrosarcoma protuberans.

Authors:  Thomas A Abrams; Scott M Schuetze
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

2.  Recurrent Dermatofibrosarcoma Protuberans of the Shoulder with Rare Distant Abdominal Metastasis detected by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT).

Authors:  Ammad Al-Tamimi; Sumbul Zaheer; Chow Kah Hoe Pierce; Saabry Osmany; Kesavan Sittampalam
Journal:  Sultan Qaboos Univ Med J       Date:  2012-07-15

3.  Reconstructive challenge of dermatofibrosarcoma protuberans in the female breast.

Authors:  Tae Hwan Park; Sang Won Seo; June Kyu Kim; Choong Hyun Chang
Journal:  World J Surg Oncol       Date:  2011-01-07       Impact factor: 2.754

4.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

Review 5.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

Review 6.  Imatinib in the treatment of solid tumours.

Authors:  Florence Duffaud; Axel Le Cesne
Journal:  Target Oncol       Date:  2009-01-27       Impact factor: 4.493

Review 7.  Targeted therapies: the rare cancer paradigm.

Authors:  Marco A Pierotti; Tiziana Negri; Elena Tamborini; Federica Perrone; Sabrina Pricl; Silvana Pilotti
Journal:  Mol Oncol       Date:  2009-10-28       Impact factor: 6.603

8.  Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.

Authors:  Piotr Rutkowski; Agnieszka Wozniak; Tomasz Switaj
Journal:  Sarcoma       Date:  2011-03-30

9.  Imatinib in the treatment of dermatofibrosarcoma protuberans.

Authors:  Stefanos V Labropoulos; Evangelia D Razis
Journal:  Biologics       Date:  2007-12

10.  Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.

Authors:  Francois G Kamar; Victor F Kairouz; Alain N Sabri
Journal:  Clin Sarcoma Res       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.